Neuro-Compass provides an up-to-date summary of all aspects of the science behind MS and reasoned advice on diagnosis, therapy, monitoring and support to assist medical staff treating people with MS in their day-to-day activities and learning.
Neuro-Compass promises just the kind of authoritative, brief and practical summaries for MS clinicians that I need to keep fully up-to-date with a rapidly changing management area.
In-depth topics on all aspects of multiple sclerosis, including CPD-accredited eLearning. Includes:
Pathophysiology: a resource to increase understanding of pathogenesis, immunopathology, remyelination and remission, neurodegeneration and progression.
Risk factors: a resource to support healthcare professionals when informing patients about the main environmental and genetic risk factors for MS.
MS subtypes and their prognosis: a resource to aid clinical recognition of the different MS subtypes
- relapsing-remitting
- primary progressive
- secondary progressive
- clinically isolated syndrome
- paediatric multiple sclerosis
- radiologically isolated syndrome
Diagnosis: a resource to support earlier and more accurate diagnosis
- McDonald diagnostic criteria
- Differential diagnosis
Measures of disease activity: a resource to support appropriate patient monitoring throughout treatment
Patient assessment tools: a resource providing expert commentary on tools for measuring disease activity
- Expanded Disability Status Scale (EDSS)
- Brief International Cognitive Assessment for MS (BICAMS)
- MS Quality of Life Index (MSQoLI)
MS imaging curriculum: a resource to optimise the use of MRI and imaging techniques in clinical practice
- CPD-accredited eLearning module on patient management considerations in RRMS
Tools to aid clinicians in everyday practice. Designed and validated by MS experts.
The MS Progression Discussion Tool is a clinician-completed tool for use by healthcare professionals in clinical practice to educate and sensitise about the risk of progressing from RRMS to SPMS and facilitate physician-patient interaction.
The Treatment Monitoring Tool provides an overview of the safety monitoring requirements for up to four DMTs at the same time.
The Treatment Evaluation Tool provides the main patient characteristics for each of the pivotal trials for all DMTs, together with the main efficacy outcomes.
Treatment guidelines and algorithms. Expert commentary on published treatment algorithms and their application in everyday clinical practice.
Treatment options. Comprehensive overview of all disease-modifying therapies, including summaries of the efficacy (annualised relapse rates; disability progression; magnetic resonance imaging) and safety profiles from key clinical trials. Also includes overview of symptomatic treatments for multiple sclerosis.
Assessing treatment response. Information on how to assess clinical response using conventional and newer measures.
Practice points. Expert commentaries on specific topics of interest for clinical practice, such as palliative care and pregnancy.
Keep up-to-date with news and alerts selected by our MS expert Steering Group and contributors. Includes:
Hot topics: In-depth analysis of topics of interest in the field of MS, curated and authored by the Steering Group and contributors.
Congress reports: Summaries of the key takeaways from recent congresses and their implications for clinical practice.
Literature alerts: Critical asssessment of recently published papers that the Steering Group consider relevant to clinical practice.
Neuro-Compass is for use by healthcare professionals only. Please try the following sites for further information on multiple sclerosis for patients:
